Sernova Biotherapeutics (FRA:PSH0) Beta: 0.4818 (As of Jun. 25, 2026)


FRA:PSH0 Sernova Biotherapeutics Inc FRA:PSH0
27 GF Score
Price €0.09
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics Beta?

Sernova Biotherapeutics FRA:PSH0 -6.00% 27 Beta is 0.4818 as of Jun. 25, 2026. GuruFocus rates FRA:PSH0 with a GF Score™ of 27/100. The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Sernova Biotherapeutics's Beta is 0.4818.


Sernova Biotherapeutics  (FRA:PSH0) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Sernova Biotherapeutics Beta Related Terms


Sernova Biotherapeutics Beta Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics Beta Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.12 1.51 1.10 1.08 0.97

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.97 0.97 0.80 0.42

FRA:PSH0 vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Sernova Biotherapeutics's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova Biotherapeutics Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Beta distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Beta falls into.


FRA:PSH0
27GF Score
Sernova Biotherapeutics Inc FRA:PSH0
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.4818 mean?
Sernova Biotherapeutics (FRA:PSH0) has a Beta of 0.4818 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Sernova Biotherapeutics and its competitors.
Is Sernova Biotherapeutics' Beta too high?
Sernova Biotherapeutics' current Beta is 0.4818. Overall, Sernova Biotherapeutics has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' Beta compare to VRTX and REGN?
Sernova Biotherapeutics' Beta of 0.4818 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current Beta is 0.4818. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (FRA:PSH0) has a current Beta of 0.4818. The current Beta is 0.4818. Sernova Biotherapeutics' overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Sernova Biotherapeutics (FRA:PSH0), the current Beta is 0.4818 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Other Exchanges SEOVF:USASVA:Canada
Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
27GF Score

Get the complete analysis for FRA:PSH0

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price